ADD ANI AS A TRUSTED SOURCE
googleads
ANI Logo
Menu
Health

Screenings may help oldies ward off cervical cancer

Washington D.C, Jul 21 (ANI): Pap smear screenings may sound terrifying, but it turns out, the brief discomfort of lying back and baring all for a stranger can actually be worth a life.

ANI Jul 21, 2016 20:11 IST googleads

Screenings may help oldies ward off cervical cancer
Washington D.C, Jul 21 (ANI): Pap smear screenings may sound terrifying, but it turns out, the brief discomfort of lying back and baring all for a stranger can actually be worth a life. A new study from the University of Illinois confirmed a link between Pap smear screenings and a lower risk of developing cervical cancer in women over age 65. However, most American health guidelines discourage women in that age range from receiving screenings unless they have pre-existing risk factors. "Some studies report that Pap smears are unnecessary in older age, while others show that there is a benefit in the over-65 age group," said cancer epidemiologist Karin Rosenblatt, adding: "There's been a great debate about it." Early research on cervical cancer screenings recommended not testing women over age 50. This suggested age cutoff for screening was increased in recent years as the disease and risk factors are better understood. "While the incidence of cervical cancer is greater in adult women under the age of 65 years, those over 65 tend to have more fatal cases of the disease," Rosenblatt said. When detected early - often via a Pap test - pre-malignant cervical cancer tissue can be removed or treated so it does not progress into malignant cancer. The team looked at Medicare billing data from 1991-99 and extracted information for more than 1,200 women who had been recently diagnosed with cervical cancer. The researchers compared their screening histories with those of more than 10,000 control patients who had no cancer diagnosis and were matched on age and geographic location. The team determined which of the patients had received a Pap test two to seven years prior to diagnosis. The results were adjusted for race and income in the regions where the subjects lived. "We found that the newly diagnosed cervical cancer group was 36 percent less likely to have had a Pap smear, compared with the control group," Rosenblatt said. "The reduction in risk was 52 percent after taking into account women in the control group who may have had hysterectomies before age 65. Both of these results were statistically significant." These results suggest that Pap tests may be beneficial for preventing malignant cervical cancer in women over 65, she said. The findings are published in the journal Gynecologic Oncology. (ANI)

Get the App

What to Read Next

Health

Scientists solve a major roadblock in cancer cell therapy: Study 

Scientists solve a major roadblock in cancer cell therapy: Study 

Researchers have found a reliable way to grow helper T cells from stem cells, solving a major challenge in immune-based cancer therapy. Helper T cells act as the immune system's coordinators, helping other immune cells fight longer and harder.

Read More
Health

Scientists find hidden synapse hotspots in the teen brain: Study

Scientists find hidden synapse hotspots in the teen brain: Study

The scientists have discovered that the adolescent brain does more than prune old connections. During the teen years, it actively builds dense new clusters of synapses in specific parts of neurons.

Read More
Health

Injection turns sleeping tumour immune cells into cancer fighters

Injection turns sleeping tumour immune cells into cancer fighters

The Korea Advanced Institute of Science and Technology (KAIST) researchers have developed a way to reprogram immune cells already inside tumours into cancer-killing machines.

Read More
Health

High-fat diets give liver cancer a dangerous head start: Study

High-fat diets give liver cancer a dangerous head start: Study

A high-fat diet does more than overload the liver with fat. New research from MIT shows that prolonged exposure to fatty foods can push liver cells into a survival mode that quietly raises the risk of cancer.

Read More
Health

Researchers have decoded rare cancer fighting plant compound

Researchers have decoded rare cancer fighting plant compound

UBC Okanagan researchers have uncovered how plants create mitraphylline, a rare natural compound linked to anti-cancer effects.

Read More
Health

Air pollution may reduce health benefits of exercise: Study

Air pollution may reduce health benefits of exercise: Study

A new study led by researchers at University College London (UCL) shows that chronic exposure to toxic air can significantly diminish the health benefits of regular physical activity.

Read More
Health

Blocking a single protein forces cancer cells to self-destruct

Blocking a single protein forces cancer cells to self-destruct

Researchers uncovered a powerful weakness in lung cancer by shutting down a protein that helps tumours survive stress.

Read More
Health

Pregnancy hypertension linked to heart risk

Pregnancy hypertension linked to heart risk

Women who experience hypertensive disorders of pregnancy (HDP) face significantly higher risks of cardiovascular complications, including heart attack, stroke, heart failure, and death, within five years of giving birth, according to a new study by Intermountain Health researchers.

Read More
Health

Single protein rewires leukemia cells to fuel their growth: Study

Single protein rewires leukemia cells to fuel their growth: Study

Researchers at the UCLA Health Jonsson Comprehensive Cancer Centre have identified a single protein, IGF2BP3, that links these two processes together in leukaemia cells. The protein alters how cells break down sugar, favouring a fast but inefficient energy pathway, while also modifying RNA that helps produce the proteins leukaemia cells need to survive and multiply.

Read More
Health

This new drug could be first to stop deadly fatty liver disease

This new drug could be first to stop deadly fatty liver disease

The Researchers at the University of California San Diego School of Medicine have identified a new investigational drug that shows promise in treating metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease linked to obesity and type 2 diabetes that can lead to cirrhosis, liver failure, and even liver cancer.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.